Literature DB >> 25835733

The carbon tetrachloride model in mice.

D Scholten1, J Trebicka2, C Liedtke1, R Weiskirchen3.   

Abstract

Recently, the need for more standardized operation procedures in experimental liver fibrosis research was suggested due to dramatic changes in European animal welfare rules. Here, we present a short series of standard operation procedures (SOPs) summarizing the most relevant and widely accepted experimental models for the induction of liver injury leading to liver fibrosis. The described procedures are based on the long-term experience of the Collaborative Research Centre 'Organ Fibrosis: From Mechanisms of Injury to Modulation of Disease' (http://www.sfbtrr57.rwth-aachen.de/), which is supported by the German Research Foundation (SFB/TRR57). These SOPs will help to improve standardization of fibrosis models and to increase the comparability of data between different laboratories with the aim of reducing animal experimentation according to the principle that was proposed in 1959 by Russell and Burch as an ethical framework for conducting scientific experiments with animals, namely the replacement, refinement and reduction (3R) principle. In the first section we focus on the carbon tetrachloride (CCl4) model in mice, which is the toxic model of liver fibrosis induction most commonly used worldwide.
© The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  cirrhosis; cytochrome P450; fibrosis; hepatotoxin; liver damage

Mesh:

Substances:

Year:  2015        PMID: 25835733     DOI: 10.1177/0023677215571192

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  67 in total

1.  Diallyl sulfide treatment protects against acetaminophen-/carbon tetrachloride-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice.

Authors:  Ming Li; Shuo Wang; Xianjie Li; Ruirui Kou; Qiong Wang; Xujing Wang; Ning Zhao; Tao Zeng; Keqin Xie
Journal:  Toxicol Res (Camb)       Date:  2018-10-25       Impact factor: 3.524

2.  Deregulated neddylation in liver fibrosis.

Authors:  Imanol Zubiete-Franco; Pablo Fernández-Tussy; Lucía Barbier-Torres; Jorge Simon; David Fernández-Ramos; Fernando Lopitz-Otsoa; Virginia Gutiérrez-de Juan; Sergio López de Davalillo; Antonio Martín Duce; Paula Iruzubieta; Daniel Taibo; Javier Crespo; Juan Caballeria; Erica Villa; Igor Aurrekoetxea; Patricia Aspichueta; Marta Varela-Rey; Shelly C Lu; José M Mato; Naiara Beraza; Teresa C Delgado; María L Martínez-Chantar
Journal:  Hepatology       Date:  2016-12-30       Impact factor: 17.425

3.  Sex-linked differences in the course of thioacetamide-induced acute liver failure in Lewis rats.

Authors:  E Koblihová; I Mrázová; Z Vaňourková; H Maxová; M Ryska; J Froněk
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

4.  Determination of in vivo biological activities of Dodonaea viscosa flowers against CCL4 toxicity in albino mice with bioactive compound detection.

Authors:  Zhao-Wei Tong; Hina Gul; Muhammad Awais; Salina Saddick; Falak Sher Khan; Muhammad Gulfraz; Umara Afzal; Khizar Nazir; M Y Malik; Sami Ullah Khan; M Ijaz Khan
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

5.  Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice.

Authors:  Shai Fuchs; Bernardo Yusta; Laurie L Baggio; Elodie M Varin; Dianne Matthews; Daniel J Drucker
Journal:  JCI Insight       Date:  2020-04-23

6.  Fibrotic liver has prompt recovery after ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Holly S Goetzman; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

Review 7.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

8.  Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin.

Authors:  Mari Saif; Wilhelmus J Kwanten; Jessica A Carr; Ivy X Chen; Jessica M Posada; Amitabh Srivastava; Juanye Zhang; Yi Zheng; Matthias Pinter; Sampurna Chatterjee; Samir Softic; C Ronald Kahn; Klaus van Leyen; Oliver T Bruns; Rakesh K Jain; Moungi G Bawendi
Journal:  Nat Biomed Eng       Date:  2020-06-22       Impact factor: 25.671

Review 9.  Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.

Authors:  Rolf Teschke; Jack Uetrecht
Journal:  Ann Transl Med       Date:  2021-04

10.  Hepatoprotective Effects of Polysaccharide from Anoectochilus roxburghii (Wall.) Lindl. on Rat Liver Injury Induced by CCl4.

Authors:  Xiaoling Yu; Lingyi Huang; Chen You; Liying Huang
Journal:  Drug Des Devel Ther       Date:  2021-07-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.